Britain’s largest drugmaker GSK has announced its support for the AllTrials campaign, in a move to further demonstrate its commitment to clinical trial transparency....

Shares in VistaGen Therapeutics have plummeted after the company reported that its lead pherine nasal spray candidate failed the first of two phase 3 trials in socia...

Eli Lilly’s diabetes and obesity therapy Tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 t...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Pha...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of Hepatitis B with a new, in-depth report. Hep...

Maximizing productivity and ROI in modern clinical trials  The development of new medications is a long, complex, and costly process. Productivity—how effici...

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes, which can compromise their care, in a...

New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care. The first-ever ...

Amid a funding drought for start-ups, the company is looking for a deal that can advance its liver cancer drug. Tempest Therapeutics is seeking a buyer or partner...

With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage expenses. Clinical trial costs have been ris...